Cargando…
Current treatment status and medical costs for hemodialysis vascular access based on analysis of the Korean Health Insurance Database
BACKGROUND/AIMS: The Republic of Korea is a country where the hemodialysis population is growing rapidly. It is believed that the numbers of treatments related to vascular access-related complications are also increasing. This study investigated the current status of treatment and medical expenses f...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234403/ https://www.ncbi.nlm.nih.gov/pubmed/30396254 http://dx.doi.org/10.3904/kjim.2018.170 |
_version_ | 1783370689924825088 |
---|---|
author | Lee, Hyung Seok Ju, Young-Su Song, Young Rim Kim, Jwa Kyung Choi, Sun Ryoung Joo, Narae Kim, Hyung Jik Park, Pyoungju Kim, Sung Gyun |
author_facet | Lee, Hyung Seok Ju, Young-Su Song, Young Rim Kim, Jwa Kyung Choi, Sun Ryoung Joo, Narae Kim, Hyung Jik Park, Pyoungju Kim, Sung Gyun |
author_sort | Lee, Hyung Seok |
collection | PubMed |
description | BACKGROUND/AIMS: The Republic of Korea is a country where the hemodialysis population is growing rapidly. It is believed that the numbers of treatments related to vascular access-related complications are also increasing. This study investigated the current status of treatment and medical expenses for vascular access in Korean patients on hemodialysis. METHODS: This was a descriptive observational study. We inspected the insurance claims of patients with chronic kidney disease who underwent hemodialysis between January 2008 and December 2016. We calculated descriptive statistics of the frequencies and medical expenses of procedures for vascular access. RESULTS: The national medical expenses for access-related treatment were 7.12 billion KRW (equivalent to 6.36 million USD) in 2008, and these expenses increased to 42.12 billion KRW (equivalent to 37.67 million USD) in 2016. The population of hemodialysis patients, the annual frequency of access-related procedures, and the total medical cost for access-related procedures increased by 1.6-, 2.6-, and 5.9-fold, respectively, over the past 9 years. The frequency and costs of access care increased as the number of patients on hemodialysis increased. The increase in vascular access-related costs has largely been driven by increased numbers of percutaneous angioplasty. CONCLUSIONS: The increasing proportion of medical costs for percutaneous angioplasty represents a challenge in the management of end-stage renal disease in Korea. It is essential to identify the clinical and physiological aspects as well as anatomical abnormalities before planning angioplasty. A timely surgical correction could be a viable option to control the rapid growth of access-related medical expenses. |
format | Online Article Text |
id | pubmed-6234403 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | The Korean Association of Internal Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-62344032018-11-16 Current treatment status and medical costs for hemodialysis vascular access based on analysis of the Korean Health Insurance Database Lee, Hyung Seok Ju, Young-Su Song, Young Rim Kim, Jwa Kyung Choi, Sun Ryoung Joo, Narae Kim, Hyung Jik Park, Pyoungju Kim, Sung Gyun Korean J Intern Med Original Article BACKGROUND/AIMS: The Republic of Korea is a country where the hemodialysis population is growing rapidly. It is believed that the numbers of treatments related to vascular access-related complications are also increasing. This study investigated the current status of treatment and medical expenses for vascular access in Korean patients on hemodialysis. METHODS: This was a descriptive observational study. We inspected the insurance claims of patients with chronic kidney disease who underwent hemodialysis between January 2008 and December 2016. We calculated descriptive statistics of the frequencies and medical expenses of procedures for vascular access. RESULTS: The national medical expenses for access-related treatment were 7.12 billion KRW (equivalent to 6.36 million USD) in 2008, and these expenses increased to 42.12 billion KRW (equivalent to 37.67 million USD) in 2016. The population of hemodialysis patients, the annual frequency of access-related procedures, and the total medical cost for access-related procedures increased by 1.6-, 2.6-, and 5.9-fold, respectively, over the past 9 years. The frequency and costs of access care increased as the number of patients on hemodialysis increased. The increase in vascular access-related costs has largely been driven by increased numbers of percutaneous angioplasty. CONCLUSIONS: The increasing proportion of medical costs for percutaneous angioplasty represents a challenge in the management of end-stage renal disease in Korea. It is essential to identify the clinical and physiological aspects as well as anatomical abnormalities before planning angioplasty. A timely surgical correction could be a viable option to control the rapid growth of access-related medical expenses. The Korean Association of Internal Medicine 2018-11 2018-10-30 /pmc/articles/PMC6234403/ /pubmed/30396254 http://dx.doi.org/10.3904/kjim.2018.170 Text en Copyright © 2018 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Lee, Hyung Seok Ju, Young-Su Song, Young Rim Kim, Jwa Kyung Choi, Sun Ryoung Joo, Narae Kim, Hyung Jik Park, Pyoungju Kim, Sung Gyun Current treatment status and medical costs for hemodialysis vascular access based on analysis of the Korean Health Insurance Database |
title | Current treatment status and medical costs for hemodialysis vascular access based on analysis of the Korean Health Insurance Database |
title_full | Current treatment status and medical costs for hemodialysis vascular access based on analysis of the Korean Health Insurance Database |
title_fullStr | Current treatment status and medical costs for hemodialysis vascular access based on analysis of the Korean Health Insurance Database |
title_full_unstemmed | Current treatment status and medical costs for hemodialysis vascular access based on analysis of the Korean Health Insurance Database |
title_short | Current treatment status and medical costs for hemodialysis vascular access based on analysis of the Korean Health Insurance Database |
title_sort | current treatment status and medical costs for hemodialysis vascular access based on analysis of the korean health insurance database |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234403/ https://www.ncbi.nlm.nih.gov/pubmed/30396254 http://dx.doi.org/10.3904/kjim.2018.170 |
work_keys_str_mv | AT leehyungseok currenttreatmentstatusandmedicalcostsforhemodialysisvascularaccessbasedonanalysisofthekoreanhealthinsurancedatabase AT juyoungsu currenttreatmentstatusandmedicalcostsforhemodialysisvascularaccessbasedonanalysisofthekoreanhealthinsurancedatabase AT songyoungrim currenttreatmentstatusandmedicalcostsforhemodialysisvascularaccessbasedonanalysisofthekoreanhealthinsurancedatabase AT kimjwakyung currenttreatmentstatusandmedicalcostsforhemodialysisvascularaccessbasedonanalysisofthekoreanhealthinsurancedatabase AT choisunryoung currenttreatmentstatusandmedicalcostsforhemodialysisvascularaccessbasedonanalysisofthekoreanhealthinsurancedatabase AT joonarae currenttreatmentstatusandmedicalcostsforhemodialysisvascularaccessbasedonanalysisofthekoreanhealthinsurancedatabase AT kimhyungjik currenttreatmentstatusandmedicalcostsforhemodialysisvascularaccessbasedonanalysisofthekoreanhealthinsurancedatabase AT parkpyoungju currenttreatmentstatusandmedicalcostsforhemodialysisvascularaccessbasedonanalysisofthekoreanhealthinsurancedatabase AT kimsunggyun currenttreatmentstatusandmedicalcostsforhemodialysisvascularaccessbasedonanalysisofthekoreanhealthinsurancedatabase |